Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Guggenheim ...

Tonix Pharmaceuticals (NASDAQ: TNXP) presented preclinical data on its novel mpox vaccine candidate, TNX-801, at the World Vaccine Congress-Europe 2024. The presentation underscored the vaccine's ...

In August 2024, Tonix announced a collaboration with Bilthoven Biologics (Bbio) to develop GMP manufacturing processes for ...

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on ELDN stock, giving a Buy rating yesterday. Thomas Smith’s ...

Noble Financial analyst Robert LeBoyer reiterated a Buy rating on Eledon Pharmaceuticals (ELDN – Research Report) today and set a price ...

Islet cell transplantation is used in type 1 diabetes to replace the insulin-producing beta cells that are destroyed by the ...

今日，Eledon ...

糖尿病，尤其是1型糖尿病（T1D），一直是一个困扰全球数百万患者的慢性疾病。许多患者每天需要注射胰岛素来控制血糖水平，这不仅给生活带来了不便，还伴随着一系列潜在的健康风险。那么，有没有可能让这些患者彻底摆脱胰岛素呢？最近的一项研究或许为我们带来了答案。 想象一下，如果有一种方法能够让糖尿病患者不再依赖胰岛素，那将是一个多么令人振奋的消息！近日，Eledon Pharmaceuticals公司公布了 ...

Eledon Pharmaceuticals reports positive Phase 1b data for tegoprubart in kidney transplants. Learn why ELDN stock could ...

One such molecule is the CD40L, which engages CD40 on dendritic and B cells of the immune system, enabling T cells to become activated as a result. Rodent studies using coreceptor blockade with ...

CHATHAM, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a ...